Optieum Biotechnologies
Latest round
- Series A
Last raised
- Jan 2025
Total raised
- $8.5M
Investors
- 7
About Optieum Biotechnologies
Founded in 2020 and based in Toon, Japan, Optieum Biotechnologies Inc operates as a biotechnology company that uses the potential of T-cells for developing treatments for cancer and other diseases. Optieum Biotechnologies specializes in advanced biopharmaceutical solutions, primarily focusing on optimizing CAR-T (Chimeric Antigen Receptor T-cell) therapies and addressing the critical unmet needs in oncology. Their core offerings enhance immune responses against various cancers, providing advancements in personalized medicine. Optieum's products are utilized in clinical trials across North America and Europe, catering to healthcare providers, research institutions, and biopharmaceutical companies seeking cancer treatment options. Optieum Biotechnologies generates revenue primarily through collaborations, licensing agreements, and clinical trial partnerships with pharmaceutical companies and healthcare institutions.
Who invested in Optieum Biotechnologies
7 investors across 1 round
See all investors in Optieum Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 14, 2025
Amount
$8.5M
Investors
Questions about Optieum Biotechnologies
Who invested in Optieum Biotechnologies?
Optieum Biotechnologies has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Optieum Biotechnologies raised?
Optieum Biotechnologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Optieum Biotechnologies last raise money?
Optieum Biotechnologies's most recent round on record is a Series A, in Jan 2025.
What does Optieum Biotechnologies do?
Founded in 2020 and based in Toon, Japan, Optieum Biotechnologies Inc operates as a biotechnology company that uses the potential of T-cells for developing treatments for cancer and other diseases.
Where is Optieum Biotechnologies headquartered?
Optieum Biotechnologies is headquartered in Japan.
Which VCs invest in companies like Optieum Biotechnologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Optieum Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Optieum Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.